Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Share News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: UBS Initiates Restaurant Group At Buy

Fri, 18th Dec 2015 09:39

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
Societe Generale Cuts Glencore Price Target To 100p From 130p, Keeps Buy
----------
EXANE BNP CUTS MARKS & SPENCER PRICE TARGET TO 580 (620) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES DIXONS CARPHONE PRICE TARGET TO 560 (510) PENCE - 'OUTPERFORM'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 2600 (2700) PENCE - 'BUY'
----------
UBS CUTS ANTOFAGASTA PRICE TARGET TO 450 (510) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIO TINTO PRICE TARGET TO 1700 (1825) PENCE - 'SELL'
----------
GOLDMAN CUTS BHP BILLITON PRICE TARGET TO 750 (925) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ANGLO AMERICAN PRICE TARGET TO 250 (280) PENCE - 'SELL'
----------
FTSE 250
----------
UBS INITIATES RESTAURANT GROUP WITH 'BUY' - TARGET 860 PENCE
----------
Numis Cuts Elementis Target To 253p From 271p, Keeps Add
----------
EXANE BNP CUTS ELEMENTIS PRICE TARGET TO 220 (250) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ELEMENTIS PRICE TARGET TO 215 (255) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS N BROWN PRICE TARGET TO 260 (280) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS HOME RETAIL PRICE TARGET TO 80 (100) PENCE - 'UNDERPERFORM'
----------
N+1 Singer Upgrades Bodycote To Buy From Hold, Price Target At 635p
----------
UBS CUTS VEDANTA PRICE TARGET TO 330 (400) PENCE - 'NEUTRAL'
----------
UBS CUTS ACACIA MINING PRICE TARGET TO 275 (300) PENCE - 'BUY'
----------
UBS CUTS BOVIS HOMES PRICE TARGET TO 1290 (1450) PENCE - 'BUY'
----------
BARCLAYS CUTS VICTREX TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 2100 (2300) PENCE
----------
BERENBERG RAISES NORTHGATE TO 'HOLD' ('SELL') - TARGET 400 (455) PENCE
----------
MAIN MARKET AND AIM
----------
Liberum Cuts PureTech Health Target To 194p From 199p, Keeps Buy
----------
Cantor Fitzgerald Cuts Bonmarche Holdings Target To 230p From 350p
----------
Cantor Fitzgerald Downgrades Bonmarche Holdings To Hold From Buy
----------
Panmure Ups Midatech Pharma Target To 476p From 417p, Keeps Buy
----------
PANMURE CUTS FENNER PRICE TARGET TO 100 (125) PENCE - 'SELL'
----------
EXANE BNP CUTS SIGNET GROUP PRICE TARGET TO 9400 (10000) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES ASOS PRICE TARGET TO 4400 (4100) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 95 (130) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 105 (215) PENCE - 'HOLD'
----------
HSBC CUTS STHREE PRICE TARGET TO 405 (425) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
23 Jun 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
17 Jun 2021 11:43

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

Read more
17 Jun 2021 11:05

Breakthrough with Q-Sphera tech sends Midatech Pharma shares up 80%

Breakthrough with Q-Sphera tech sends Midatech Pharma shares up 80%

Read more
30 Apr 2021 16:32

TRADING UPDATES: Asimilar and Worldsec swing to profit

TRADING UPDATES: Asimilar and Worldsec swing to profit

Read more
25 Mar 2021 17:42

IN BRIEF: Midatech Pharma 2020 loss widens; closes Spanish unit

IN BRIEF: Midatech Pharma 2020 loss widens; closes Spanish unit

Read more
26 Jan 2021 19:25

TRADING UPDATES: Manolete Sets Records; Ergomed Earnings Top Forecasts

TRADING UPDATES: Manolete Sets Records; Ergomed Earnings Top Forecasts

Read more
19 Oct 2020 12:52

Midatech reports 'encouraging' results from MTX110 study

(Sharecast News) - Biotechnology company Midatech Pharma announced "encouraging" headline results from a phase 1 study at the University of California, San Francisco (UCSF) in patients with diffuse intrinsic pontine glioma (DIPG) on Monday.

Read more
19 Oct 2020 10:45

Midatech Pharma Encouraged By Phase One Study Results For MTX110

Midatech Pharma Encouraged By Phase One Study Results For MTX110

Read more
19 Oct 2020 10:26

UK WINNERS & LOSERS SUMMARY: boohoo Down 11% As Weekend Press Weighs

UK WINNERS & LOSERS SUMMARY: boohoo Down 11% As Weekend Press Weighs

Read more
10 Sep 2020 14:57

IN BRIEF: Midatech Pharma Loss Widens In First Half On Lower Revenue

IN BRIEF: Midatech Pharma Loss Widens In First Half On Lower Revenue

Read more
3 Sep 2020 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
19 Aug 2020 11:35

Midatech Pharma Raises USD1 Million From US Warrants Exercise

Midatech Pharma Raises USD1 Million From US Warrants Exercise

Read more
27 Jul 2020 11:25

Midatech raises £5m to fund Q-Sphera development

(Sharecast News) - Drug delivery technology company Midatech Pharma has raised £5m before expenses via a placing to investors in the UK, it announced on Monday, to advance and develop its 'Q-Sphera' products and technology, and for general corporate purposes.

Read more
27 Jul 2020 10:56

Midatech Pharma Placing And Broker Option Raises Almost GBP6 Million

Midatech Pharma Placing And Broker Option Raises Almost GBP6 Million

Read more
24 Jul 2020 17:24

IN BRIEF: Midatech Pharma Terminates Formal Sales Process

IN BRIEF: Midatech Pharma Terminates Formal Sales Process

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.